Intellinetics, Inc. (INLX) — This stock currently has no analyst coverage. No price targets, ratings, or earnings estimates are available. This is common for preferred shares, warrants, OTC-traded securities, and smaller companies that are not followed by Wall Street analysts.
Los analistas estiman Beneficio por acción (EPS) de $-0.19 y ingresos de $0.02B para el próximo año fiscal.
Historial de Beneficio por acción (EPS): 2024: real $-0.13 vs est $-0.19 (superó +31.6%). 2025: real $-0.44 vs est $-0.46 (superó +4.3%). Precisión del analista: 75%.
Estimaciones de BPA — INLX
75%
Analyst Accuracy
Fair
2 years compared
Actual vs Estimate
2024
Actual –$0.13
vs Est –$0.19
▲ 46.2% off
2025
Actual –$0.44
vs Est –$0.46
▲ 4.5% off
Profitability Outlook
Company has been making losses in all recent fiscal years. Analysts expect losses to continue near-term.
Estimaciones de Ingresos — INLX
99%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024
Actual $0.018B
vs Est $0.018B
▲ 0.7% off
2025
Actual $0.017B
vs Est $0.016B
▲ 1.1% off
Revenue Trend
Revenue has been relatively flat. Analysts expect stable revenue going forward.